A key role of the SCN is to meet the informational needs of people affected by cancer receiving antineoplastic agents. Education of people receiving antineoplastic agents can: 1
- provide support and knowledge to empower them to manage self-care effectively
- reduce fear
- increase self-confidence
- improve compliance.
Before administering antineoplastic agents, valid informed consent is required.1
Education for the person receiving antineoplastic agents should involve:16
- a coordinated multidisciplinary approach
- timely documentation
- verbal and written information providing the aims, effects and likely outcomes of treatment
- a list of appropriate websites
- information reinforced on subsequent visits
- medication guides and diaries.
For further information access the supporting modules:
- EdCaN module: Cancer Treatment Planning.
- EdCaN module: Cancer Supportive Care Principles.
Access pp. 12-14 of the Guidelines for the Safe Prescribing, Supply and Administration of Cancer Chemotherapy(PDF, 213KB)16, and document a detailed education plan for a person receiving antineoplastic agents.
Access Evaluation of the addition of video-based education for patients receiving standard pre-chemotherapy education24 (free article, but you must register and login to access it) and critically discuss the role of various forms of media (print, internet, video) in providing education for people receiving antineoplastic agents.
Identify key websites you would recommend to support the information needs of people receiving antineoplastic agents, providing a justification for your recommendation.
Outline the process of obtaining and documenting informed consent prior to administration of antineoplastic agents.
Discuss the ethical and professional responsibility of the SCN in the process of informed consent.